racemetirosine has been researched along with thiazolyl blue in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, C; Dai, L; Peng, YP; Qiu, YH | 1 |
| Kerk, S; Meng Lim, T; Zhou, Z | 1 |
2 other study(ies) available for racemetirosine and thiazolyl blue
| Article | Year |
|---|---|
Effect of endogenous catecholamines in lymphocytes on lymphocyte function.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; alpha-Methyltyrosine; Analysis of Variance; Animals; Blotting, Northern; Catecholamines; Cell Proliferation; Cells, Cultured; Chromatography, High Pressure Liquid; Concanavalin A; Cyclic AMP; Dose-Response Relationship, Drug; Drug Interactions; Electrochemistry; Enzyme Inhibitors; Lymphocyte Activation; Lymphocytes; Pargyline; Phentolamine; Propranolol; Radioimmunoassay; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazolium Salts; Thiazoles; Tyrosine 3-Monooxygenase | 2005 |
Endogenous dopamine (DA) renders dopaminergic cells vulnerable to challenge of proteasome inhibitor MG132.
Topics: alpha-Methyltyrosine; Animals; Cell Survival; Cysteine Proteinase Inhibitors; Dopamine; Leupeptins; Malondialdehyde; Mice; Neurodegenerative Diseases; Neurons; Parkinson Disease; PC12 Cells; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Rats; Tetrazolium Salts; Thiazoles | 2008 |